SXTC VS MOTS Stock Comparison

Performance

SXTC
10/100

SXTC returned -87.22% in the last 12 months. Based on SPY's performance of -11.50%, its performance is below average giving it a score of 10 of 100.

MOTS
10/100

MOTS returned -83.15% in the last 12 months. Based on SPY's performance of -13.96%, its performance is below average giving it a score of 10 of 100.

Technicals

SXTC
21/100

SXTC receives a 21 of 100 based on 14 indicators. 2 are bullish, 10 are bearish.

MOTS
18/100

MOTS receives a 17 of 100 based on 14 indicators. 2 are bullish, 11 are bearish.

Profit

SXTC
63/100

Out of the last 8 quarters, SXTC has had 7 profitable quarters and has increased their profits year over year on 2 of them.

MOTS
10/100

Out of the last 20 quarters, MOTS has had 0 profitable quarters and has increased their profits year over year on 1 of them.

Volatility

SXTC
40/100

SXTC has had a lower than average amount of volatility over the last 12 months giving it a score of 40 of 100.

MOTS
46/100

MOTS has had a lower than average amount of volatility over the last 12 months giving it a score of 45 of 100.

Analyst Price Targets

SXTC

"Analyst Price Targets" not found for SXTC

MOTS
88/100

2 analysts offer 12-month price targets for MOTS. Together, they have an average target of 0, the most optimistic target put MOTS at 0 within 12-months and the most pessimistic has MOTS at 0.

Earnings

SXTC

"Earnings" not found for SXTC

MOTS
74/100

MOTS has missed earnings 2 times in the last 20 quarters.

All score calculations are broken down here to help you make more informed investing decisions

China SXT Pharmaceuticals, Inc. Ordinary Shares Summary

Nasdaq / SXTC

Healthcare

Drug Manufacturers - Specialty & Generic

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine piece tablets (TCMP) in China. The company offers advanced, fine, and regular TCMP products, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. As of March 31, 2022, it had an end-customer base of 68 pharmaceutical companies, 14 chain pharmacies, and 20 hospitals in 10 provinces and municipalities in China. The company was founded in 2005 and is headquartered in Taizhou, China.

Motus GI Holdings, Inc. Common Stock Summary

Nasdaq / MOTS

Healthcare

Medical - Devices

Motus GI Holdings, Inc., a medical technology company, develops Pure-Vu system, a medical device to facilitate the cleaning of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedure. The company was incorporated in 2016 and is based in Fort Lauderdale, Florida.

Power up your portfolio